Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Hoffmann-La Roche synthesizes new PDE10A inhibitors for psychotic disorders

Dec. 18, 2013

Ares Trading presents novel BACE1 inhibitors for neurodegenerative disorders

Dec. 18, 2013

Targacept reports topline results from phase IIb study of TC-5619 for schizophrenia

Dec. 17, 2013

AcelRx and Grunenthal establish commercial collaboration for Zalviso in E.U.

Dec. 17, 2013

The Jerome Lejeune Foundation provides grants to four U.S. researchers

Dec. 17, 2013

New GR antagonists prepared by Concept Therapeutics

Dec. 17, 2013

Bristol-Myers Squibb designs new nAChR agonists

Dec. 17, 2013

Novel glutamate transporter modulator has protective effects in neurological disease models

Dec. 17, 2013

Dementia Consortium launched in the UK to advance drug development

Dec. 16, 2013

Canadian approval for Lemtrada

Dec. 16, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...